Cargando…
Assessing the Impact of the COVID-19 outbreak on the oncological practice regarding metastatic breast cancer patients treated with CDK4/6 inhibitors
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955164/ http://dx.doi.org/10.1016/S0960-9776(21)00256-3 |
| _version_ | 1783664206507147264 |
|---|---|
| author | Fouda, M. Kuriakose, V. |
| author_facet | Fouda, M. Kuriakose, V. |
| author_sort | Fouda, M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7955164 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79551642021-03-15 Assessing the Impact of the COVID-19 outbreak on the oncological practice regarding metastatic breast cancer patients treated with CDK4/6 inhibitors Fouda, M. Kuriakose, V. Breast Poster Abstracts: Other Elsevier Ltd. Published by Elsevier Ltd. 2021-04 2021-03-13 /pmc/articles/PMC7955164/ http://dx.doi.org/10.1016/S0960-9776(21)00256-3 Text en Copyright © 2021 Elsevier Ltd. Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Abstracts: Other Fouda, M. Kuriakose, V. Assessing the Impact of the COVID-19 outbreak on the oncological practice regarding metastatic breast cancer patients treated with CDK4/6 inhibitors |
| title | Assessing the Impact of the COVID-19 outbreak on the oncological practice regarding metastatic breast cancer patients treated with CDK4/6 inhibitors |
| title_full | Assessing the Impact of the COVID-19 outbreak on the oncological practice regarding metastatic breast cancer patients treated with CDK4/6 inhibitors |
| title_fullStr | Assessing the Impact of the COVID-19 outbreak on the oncological practice regarding metastatic breast cancer patients treated with CDK4/6 inhibitors |
| title_full_unstemmed | Assessing the Impact of the COVID-19 outbreak on the oncological practice regarding metastatic breast cancer patients treated with CDK4/6 inhibitors |
| title_short | Assessing the Impact of the COVID-19 outbreak on the oncological practice regarding metastatic breast cancer patients treated with CDK4/6 inhibitors |
| title_sort | assessing the impact of the covid-19 outbreak on the oncological practice regarding metastatic breast cancer patients treated with cdk4/6 inhibitors |
| topic | Poster Abstracts: Other |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955164/ http://dx.doi.org/10.1016/S0960-9776(21)00256-3 |
| work_keys_str_mv | AT foudam assessingtheimpactofthecovid19outbreakontheoncologicalpracticeregardingmetastaticbreastcancerpatientstreatedwithcdk46inhibitors AT kuriakosev assessingtheimpactofthecovid19outbreakontheoncologicalpracticeregardingmetastaticbreastcancerpatientstreatedwithcdk46inhibitors |